iRhythm Holdings, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureOct 5 →Insiders1 insider bought $56,892 in 1 open-market buy. 10 insiders sold $21.9M, 20 of 55 sales on a 10b5-1 plan.→HoldersBlackRock 9.1%RTW Investments 6.6%Vanguard Portfolio 5.8%→Financing →PeersClosest companies: DXCM, LUNG, CBLL→
From the filings
Figures
- Revenue
- $825.3Mlast 12 months
- Net income
- −$14.4Mlast 12 months
- Operating cash flow
- $62.6Mlast 12 months
- Cash and equivalents
- $246.7Mat the last balance sheet
- Shares outstanding
- 32.9M shareson issue